News Category
Onco-Innovations' potential acquisition of an exclusive option on Ifowonco's oral LAG-3 inhibitor program could combine DNA damage response inhibition...
A new study in Circulation: Population Health and Outcomes found that nearly 80% of young adults aged around 23 have early signs of cardiovascular-kid...
Quantum BioPharma is advancing a novel multiple sclerosis therapy that focuses on protecting myelin and addressing smoldering lesions, potentially off...
A new mathematical study proposes a solution to a long-standing mystery in melanoma therapy, potentially improving immunotherapy approaches.
Quantum BioPharma's Lucid-MS, a novel myelin-protecting therapy, progresses to phase 2 trials, signaling a shift in MS treatment beyond immune suppres...
VERAXA Biotech's collaboration with Ardigen uses AI to optimize its BiTAC platform, potentially improving target validation and reducing development r...
Scientists have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, offering ...
NanoViricides is set to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more practical treatment opti...
The 20th Annual Sickle Cell Disease Educational Summit, hosted by Cayenne Wellness Center, celebrates two decades of progress while highlighting new t...
Helix BioPharma's appointment of Dr. Markus Loeffler as CMO is a strategic move to accelerate its oncology pipeline, including the upcoming Phase Ib/I...
The summit aims to improve sickle cell education, health equity, and access to care for Hispanic and Latino communities through culturally relevant pr...
Two $200,000 grants will fund research into the lung microbiome's role in cancer development and mechanisms of drug resistance, aiming to improve earl...
Maria Cristina Swiman's 'Silence Across Three Continents' recounts her true story of love, loss, and resilience, highlighting the challenges of intern...
A comprehensive review in World Journal of Pediatric Surgery synthesizes current evidence on surgical management of necrotizing enterocolitis, emphasi...
Helix BioPharma reshuffles its board, appointing CEO Thomas Mehrling as director following Janusz Grabski's resignation, to better align governance wi...
Onco-Innovations is progressing its precision oncology candidate ONC010 through IND-enabling activities, positioning itself in the expanding field of ...
Researchers at the University of Manchester discovered that a small group of immune cells, often overlooked, are crucial for mobilizing and sustaining...
Lantern Pharma's Q2 2026 results highlight progress in its AI-driven oncology pipeline, including promising LP-300 trial data and the establishment of...
NeOnc Technologies reported positive Phase 2a data for NEO100 in recurrent brain cancer, with significant survival benefits and regulatory clarity, po...
GeoVax announces its preparedness to contribute its MVA-based hemorrhagic fever vaccine expertise and candidates to the global response against the ra...
Kyle Brown's attendance at ALS Arizona's Bite Nite gala underscores the law firm's commitment to supporting families affected by ALS through community...
NanoViricides received approval to conduct a Phase II trial of its oral antiviral NV-387 against the ongoing Ebola outbreak in the DRC, potentially of...
New research from the University of Virginia suggests focused ultrasound could enhance drug delivery to deadly brain tumors, potentially improving tre...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
A new narrative review provides a comprehensive framework for risk-adapted neuroblastoma care, emphasizing molecular and clinical factors to tailor tr...
Quantum BioPharma is progressing its investigational MS therapy Lucid-MS and its supplement unbuzzd, addressing both myelin repair and alcohol metabol...
A case in Spain where a patient's neurocysticercosis mimicked brain cancer highlights the diagnostic challenges and the urgent need for better treatme...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, undersco...
The Keep A Breast Foundation's 2026 High Desert Collection transforms chest casts into art to spark conversations about breast health, launching a com...
A new liquid biopsy offers a simple way to forecast which advanced lung cancer patients will benefit from immunotherapy, potentially aiding drug devel...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Onco-Innovations' integrated approach to cancer drug development, leveraging PNKP-targeted DDR inhibition, nanoparticle delivery, and AI, represents a...
Nagoya University researchers discovered that the immune protein C3, when produced by tumor cells, may boost the effectiveness of immunotherapy, offer...
VolitionRx's new Capture-Seq technology isolates over 99% pure circulating tumor DNA, potentially enabling earlier cancer detection and monitoring, wi...
VERAXA Biotech's VXA-222 bispecific ADC program moves past discovery, and the company strengthens its IP estate with new patent filings, underpinning ...
The American Heart Association's 2026 Get With The Guidelines awards recognize over 3,000 hospitals for improving heart disease and stroke outcomes, w...
The US surpasses 2025's total measles cases with 2,371 infections, the highest in 30 years, prompting intensified public health responses.
Oncotelic Therapeutics will showcase its advancements in intravenous Everolimus trials, Deciparticle platform validation, and AI-driven drug discovery...
GeoVax underscores recent independent research suggesting cross-reactive immune responses to ebolaviruses, reinforcing the strategic value of its MVA-...
Amber Dermatology, founded by board-certified dermatologist Dr. Alyssa Miceli, opens in Trumbull, CT, aiming to provide a more personal and transparen...
Experts warn that climate change is accelerating the spread of infectious diseases, urging policymakers to take the threat seriously, with companies l...
VERAXA Biotech strengthens its scientific leadership by appointing Dr. Christoph Erkel as Chief Scientific Officer to advance its proprietary BiTAC® c...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP, with proceeds earmarked for adva...
Dr. Lee Newcomer, a former UnitedHealthcare chief medical officer and health policy expert, has signed with Creative Management Partners to promote hi...
A new preclinical study reveals an experimental therapy containing vitamin B12 could stop the progression of glioblastoma multiforme, the deadliest br...
VolitionRx announces increasing clinical support for its Nu.Q NETs assay as a biomarker for sepsis, with multiple peer-reviewed studies showing its ab...
VERAXA Biotech (VRXA) filed new patent applications in 2025, expanding its portfolio to over 50 granted patents across 14 countries, aiming to protect...
VERAXA Biotech strengthens its scientific leadership with Dr. Christoph Erkel as CSO, advancing its proprietary BiTAC(R) platform toward clinical deve...
